找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: MHC Class-I Loss and Cancer Immune Escape; Federico Garrido Book 2019 Springer Nature Switzerland AG 2019 tumor.immune escape.T lymphocyte

[復(fù)制鏈接]
樓主: 爆發(fā)
11#
發(fā)表于 2025-3-23 13:13:45 | 只看該作者
12#
發(fā)表于 2025-3-23 16:44:27 | 只看該作者
MHC/HLA Class I Loss in Cancer Cells,LA class-I phenotypes can be observed that are produced by different molecular mechanisms. Experimental and histological evidences are summarized indicating that at the early stages of tumour development there is an enormous variety of tumour clones with different MHC class I expression patterns. Th
13#
發(fā)表于 2025-3-23 21:23:14 | 只看該作者
HLA Class-I Expression and Cancer Immunotherapy,py? Are T lymphocytes responsible for tumour rejection and how these responses can be boosted? These questions are discussed in the context of the molecular mechanisms responsible for MHC/HLA class I alterations. If the metastatic tumour cells harbor “irreversible/hard” HLA lesions, they will escape
14#
發(fā)表于 2025-3-24 02:15:27 | 只看該作者
Book 2019“Antigen Presenting Molecules” and the “T Lymphocytes”. The former are known as the Major Histocompatibility Complex (MHC): the H-2 and the HLA molecules. The latter are a subgroup of white cells travelling all over our body which are capable to distinguish between “self and non self”...Readers will
15#
發(fā)表于 2025-3-24 04:37:46 | 只看該作者
Introduction,research have important implications for the new generation of cancer immunotherapy that boosts T cell responses. A historical perspective of major discoveries is presented in this chapter, with the names of the scientists that have made a significant contribution to the enormous progress made in the field of Tumour Immunology.
16#
發(fā)表于 2025-3-24 09:24:04 | 只看該作者
17#
發(fā)表于 2025-3-24 14:20:06 | 只看該作者
0065-2598 cape strategies used by cancer cells to avoid the immune response of the host. The main characters of this story are the “Antigen Presenting Molecules” and the “T Lymphocytes”. The former are known as the Major Histocompatibility Complex (MHC): the H-2 and the HLA molecules. The latter are a subgrou
18#
發(fā)表于 2025-3-24 18:27:57 | 只看該作者
MHC/HLA Class I Loss in Cancer Cells,the generation of different tumor cell clones with altered MHC class I phenotypes, which could be similar or different from the original tumor clone. The biological and immunological relevance of these observations is discussed. Finally, the interesting phenomenon of metastatic dormancy is analyzed
19#
發(fā)表于 2025-3-24 20:41:19 | 只看該作者
Book 2019 stimulating T lymphocytes to destroy tumor cells. However, the clinical response rate is not as high as expected. The molecular mechanisms responsible for MHC/HLA antigen loss play a crucial role in this resistance to immunotherapy. This immune escape mechanism will be discussed in different types
20#
發(fā)表于 2025-3-25 00:18:01 | 只看該作者
Federico Garridoden.. Eine ?hnliche Aufgabe zur Nachprüfung von Pers?nlichkeit und Sp?tschicksal stellte sich . in seinen Studien über eingeschriebene Prostituierte, die 1926 durch die Kata-mnesen . erg?nzt wurden ; . untersuchte den geisteskranken Strafgefangenen, . den Landstreicher in seinem Lebensgange.; auf de
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-25 01:31
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
专栏| 临沧市| 怀安县| 贵定县| 崇信县| 米泉市| 巧家县| 广州市| 邹城市| 蒙城县| 陆良县| 西华县| 奎屯市| 即墨市| 锡林浩特市| 嘉定区| 遵义市| 灌云县| 赤壁市| 环江| 克东县| 平邑县| 浦县| 永登县| 饶阳县| 沂源县| 凭祥市| 纳雍县| 察雅县| 富蕴县| 东乌珠穆沁旗| 安阳市| 四川省| 镇坪县| 清水县| 元氏县| 朔州市| 苏尼特右旗| 崇义县| 宜春市| 临海市|